163 related articles for article (PubMed ID: 35105872)
1. DNA-methylation dynamics across short-term, exposure-containing CBT in patients with panic disorder.
Moser S; Martins J; Czamara D; Lange J; Müller-Myhsok B; Erhardt A
Transl Psychiatry; 2022 Feb; 12(1):46. PubMed ID: 35105872
[TBL] [Abstract][Full Text] [Related]
2. The DNA methylome in panic disorder: a case-control and longitudinal psychotherapy-epigenetic study.
Ziegler C; Grundner-Culemann F; Schiele MA; Schlosser P; Kollert L; Mahr M; Gajewska A; Lesch KP; Deckert J; Köttgen A; Domschke K
Transl Psychiatry; 2019 Nov; 9(1):314. PubMed ID: 31754096
[TBL] [Abstract][Full Text] [Related]
3. Epigenome-wide association study of DNA methylation in panic disorder.
Shimada-Sugimoto M; Otowa T; Miyagawa T; Umekage T; Kawamura Y; Bundo M; Iwamoto K; Tochigi M; Kasai K; Kaiya H; Tanii H; Okazaki Y; Tokunaga K; Sasaki T
Clin Epigenetics; 2017; 9():6. PubMed ID: 28149334
[TBL] [Abstract][Full Text] [Related]
4. Altered immune phenotype and DNA methylation in panic disorder.
Petersen CL; Chen JQ; Salas LA; Christensen BC
Clin Epigenetics; 2020 Nov; 12(1):177. PubMed ID: 33208194
[TBL] [Abstract][Full Text] [Related]
5. MAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapy.
Ziegler C; Richter J; Mahr M; Gajewska A; Schiele MA; Gehrmann A; Schmidt B; Lesch KP; Lang T; Helbig-Lang S; Pauli P; Kircher T; Reif A; Rief W; Vossbeck-Elsebusch AN; Arolt V; Wittchen HU; Hamm AO; Deckert J; Domschke K
Transl Psychiatry; 2016 Apr; 6(4):e773. PubMed ID: 27045843
[TBL] [Abstract][Full Text] [Related]
6. The COMTval158met polymorphism is associated with symptom relief during exposure-based cognitive-behavioral treatment in panic disorder.
Lonsdorf TB; Rück C; Bergström J; Andersson G; Ohman A; Lindefors N; Schalling M
BMC Psychiatry; 2010 Nov; 10():99. PubMed ID: 21110842
[TBL] [Abstract][Full Text] [Related]
7. Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes.
Gottschalk MG; Richter J; Ziegler C; Schiele MA; Mann J; Geiger MJ; Schartner C; Homola GA; Alpers GW; Büchel C; Fehm L; Fydrich T; Gerlach AL; Gloster AT; Helbig-Lang S; Kalisch R; Kircher T; Lang T; Lonsdorf TB; Pané-Farré CA; Ströhle A; Weber H; Zwanzger P; Arolt V; Romanos M; Wittchen HU; Hamm A; Pauli P; Reif A; Deckert J; Neufang S; Höfler M; Domschke K
Transl Psychiatry; 2019 Feb; 9(1):75. PubMed ID: 30718541
[TBL] [Abstract][Full Text] [Related]
8. Investigating effective treatment factors in brief cognitive behavioral therapy for panic disorder.
Lim JA; Lee YI; Jang JH; Choi SH
Medicine (Baltimore); 2018 Sep; 97(38):e12422. PubMed ID: 30235717
[TBL] [Abstract][Full Text] [Related]
9. Integrated genome-wide methylation and expression analyses provide predictors of diagnosis and early response to antidepressant in panic disorder.
Zou Z; Zhang Y; Huang Y; Wang J; Min W; Xiang M; Zhou B; Li T
J Affect Disord; 2023 Feb; 322():146-155. PubMed ID: 36356898
[TBL] [Abstract][Full Text] [Related]
10. Sensitization of catastrophic cognition in cognitive-behavioral therapy for panic disorder.
Noda Y; Nakano Y; Lee K; Ogawa S; Kinoshita Y; Funayama T; Watanabe N; Chen J; Noguchi Y; Kataoka M; Suzuki M; Furukawa TA
BMC Psychiatry; 2007 Dec; 7():70. PubMed ID: 18067686
[TBL] [Abstract][Full Text] [Related]
11. "DNA Methylation signatures in panic disorder".
Iurato S; Carrillo-Roa T; Arloth J; Czamara D; Diener-Hölzl L; Lange J; Müller-Myhsok B; Binder EB; Erhardt A
Transl Psychiatry; 2017 Dec; 7(12):1287. PubMed ID: 29249830
[TBL] [Abstract][Full Text] [Related]
12. The impact of depressive comorbidity on neural plasticity following cognitive-behavioral therapy in panic disorder with agoraphobia.
Kunas SL; Yang Y; Straube B; Kircher T; Gerlach AL; Pfleiderer B; Arolt V; Wittmann A; Stroehle A; Wittchen HU; Lueken U
J Affect Disord; 2019 Feb; 245():451-460. PubMed ID: 30428445
[TBL] [Abstract][Full Text] [Related]
13. Exploring the effect of antenatal depression treatment on children's epigenetic profiles: findings from a pilot randomized controlled trial.
Bleker LS; Milgrom J; Sexton-Oates A; Roseboom TJ; Gemmill AW; Holt CJ; Saffery R; Burger H; de Rooij SR
Clin Epigenetics; 2019 Feb; 11(1):18. PubMed ID: 30717815
[TBL] [Abstract][Full Text] [Related]
14. N-methyl-D-aspartate Partial Agonist Enhanced Intensive Cognitive-Behavioral Therapy of Panic Disorder in Adolescents.
Leyfer O; Carpenter A; Pincus D
Child Psychiatry Hum Dev; 2019 Apr; 50(2):268-277. PubMed ID: 30078111
[TBL] [Abstract][Full Text] [Related]
15. The neural correlates of cognitive behavioral therapy: recent progress in the investigation of patients with panic disorder.
Yang Y; Kircher T; Straube B
Behav Res Ther; 2014 Nov; 62():88-96. PubMed ID: 25124776
[TBL] [Abstract][Full Text] [Related]
16. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.
Gloster AT; Wittchen HU; Einsle F; Lang T; Helbig-Lang S; Fydrich T; Fehm L; Hamm AO; Richter J; Alpers GW; Gerlach AL; Ströhle A; Kircher T; Deckert J; Zwanzger P; Höfler M; Arolt V
J Consult Clin Psychol; 2011 Jun; 79(3):406-20. PubMed ID: 21534651
[TBL] [Abstract][Full Text] [Related]
17. Effects of stressful life-events on DNA methylation in panic disorder and major depressive disorder.
Czamara D; Neufang A; Dieterle R; Iurato S; Arloth J; Martins J; Ising M; Binder EE; Erhardt A
Clin Epigenetics; 2022 Apr; 14(1):55. PubMed ID: 35477560
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of change in cognitive behavioral therapy for panic disorder: the unique effects of self-efficacy and anxiety sensitivity.
Gallagher MW; Payne LA; White KS; Shear KM; Woods SW; Gorman JM; Barlow DH
Behav Res Ther; 2013 Nov; 51(11):767-77. PubMed ID: 24095901
[TBL] [Abstract][Full Text] [Related]
19. A review of cognitive behavioral therapy for panic disorder in patients with chronic obstructive pulmonary disease: the rationale for interoceptive exposure.
Barrera TL; Grubbs KM; Kunik ME; Teng EJ
J Clin Psychol Med Settings; 2014 Jun; 21(2):144-54. PubMed ID: 24699909
[TBL] [Abstract][Full Text] [Related]
20. Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder/agoraphobia during cognitive-behavioural therapy.
Deppermann S; Vennewald N; Diemer J; Sickinger S; Haeussinger FB; Dresler T; Notzon S; Laeger I; Arolt V; Ehlis AC; Fallgatter AJ; Zwanzger P
Neuroimage Clin; 2017; 16():668-677. PubMed ID: 29085773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
